News & Updates

Cognitive decline may be slower among older adults who have been long-time pet owners, reports a study presented at the recently concluded Annual Meeting of the American Academy of Neurology (AAN 2022).

Implantation with new-generation, self-expanding aortic valves appears to result in a significant spike in the rates of high-degree cardiac conduction disturbance, such as an increase in PR and QRS intervals, reports a new study.

In patients suffering from severe septic shock, energy deficit improves during the first week of intensive care unit stay, accompanied by relatively stable resting energy expenditure and respiratory quotient, a recent study has found.

In acute coronary syndrome (ACS) patients who have undergone percutaneous coronary intervention (PCI), early treatment with evolocumab as an addition to statin can lower low-density lipoprotein cholesterol (LDL-C) levels as well as reduce the incidence of recurrent ischemic cardiovascular events, while having satisfactory tolerability and safety, according to a study.

The risks of cardiovascular disease (CVD) mortality appear to be higher among adults with elevated late nonfasting plasma glucose (PG) levels independently of glycated haemoglobin (HbA1c), a recent study reports.

Prior faecal haemoglobin (F-Hb) concentrations are prognostic of the risk of developing colorectal cancer (CRC) or advanced neoplasia (AN), according to a study. When added to age and sex, prior F-Hb concentrations can accurately identify individuals at risk of the said diseases.

Treatment with fezolinetant significantly reduced the frequency and severity of vasomotor symptoms (VMS), particularly hot flashes, in women during their menopausal phase, according to the SKYLIGHT 1* trial presented at ACOG 2022.